Clinical Trial Update: Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating LMB-2 with fludarabine and cyclophosphamide in adults with Adult T-Cell Leukemia; study status completed with results posted in 2017…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• LMB-2

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult T-Cell Leukemia (ATL) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-09-08